1. Halpern M.T., Zilberberg M.D., Schmier J.K. et al. Anemia, costs and mortality in chronic obstructive pulmonary dis ease. Cost Effectiveness and Resource Allocation 2006, 4: 17.

2. Pancirov D., Radišić Biljak V., Stjepanović G. et al. Hematological markers of anemia and Creactive protein in patients with stable chronic obstructive pulmonary disease. Biochem. Med. 2009; 19 (3): 266–276.

3. John M., Lange A., Hoernig S. et al. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int. J. Cardiol. 2006; 111: 365–370.

4. Cote C., Zilberberg M.D., Mody S.H. et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur. Respir. J. 2007; 29: 923–929.

5. Boutou A.K., Pitsiou G.G., Stanopoulos I. et al. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a casecon trol study. Q.J.M. 2012; 105 (7): 657.

6. Martinez/Rivera C., Portillo K., Muñoz/Ferrer A. et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012; 9 (3): 243–250.

7. Rasmussen L., Christensen S., Lenler/Petersen P. et al. Anemia and 90day mortality in COPD patients requiring invasive mechanical ventilation. Clin. Epidemiol. 2010; 3 (1): 1–5.

8. Almagro P., Lopez F., Cabrera F.J. et al. Comorbidities in patients hospitalized due to chronic obstructive pulmonary disease. A comparative analysis of the ECCO and ESMI studies. Rev. Clin. Esp. 2012; 212 (6): 281–286.

9. De Lucas/Ramos P., Isquierdo/Alonso J.L., Rodriguez/Gonzalez Moro J.M. et al. Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study. Arch. Bronconeumol 2008; 44 (5): 233–238.

10. Преображенский Д.В., Талызина И.В., Сидоренко Б.А. и др. Правожелудочковая сердечная недостаточность у госпитализированных больных с хронической обструктивной болезнью легких: частота и клиникоинструментальные особенности. Кардиология 2009; 7–8: 42–45.